Rockefeller Capital Management’s Insmed INSM Stock Holding History

Rockefeller Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21M	Sell	7,429 -9,346	-56%	-$1.44M	﹤0.01%	1522
2025 Q4	$2.92M	Buy	16,775 +7,863	+88%	+$1.43M	0.01%	1090
2025 Q3	$1.28M	Buy	+8,912	New	+$1.09M	﹤0.01%	1313
2023 Q1	–	Sell	-430	Closed	-$8K	–	2919
2022 Q4	$8K	Buy	430 +307	+250%	+$5.93K	﹤0.01%	3180
2022 Q3	$2K	Sell	123 -668	-84%	-$16K	﹤0.01%	3597
2022 Q2	$15K	Buy	791 +640	+424%	+$13.4K	﹤0.01%	2902
2022 Q1	$3K	Sell	151 -268	-64%	-$6.23K	﹤0.01%	3510
2021 Q4	$11K	Sell	419 -1,081	-72%	-$30.9K	﹤0.01%	2926
2021 Q3	$41K	Buy	1,500 +1,466	+4,312%	+$38.5K	﹤0.01%	2228
2021 Q2	$0	Buy	+34	New	+$1.01K	﹤0.01%	3518
2020 Q4	–	Sell	-149	Closed	-$4K	–	2931
2020 Q3	$4K	Buy	149 +56	+60%	+$1.61K	﹤0.01%	2286
2020 Q2	$3K	Sell	93 -53	-36%	-$1.26K	﹤0.01%	2231
2020 Q1	$2K	Buy	+146	New	+$3.46K	﹤0.01%	2181

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rockefeller Capital Management's INSM Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Insmed (INSM) stake by 56% in Q1 2026, selling an estimated $1.44M and leaving 7,429 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Rockefeller Capital Management first reported a position in INSM in Q1 2020 and has held it in 13 quarters since. The position peaked at $2.92M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Rockefeller Capital Management held 7,429 shares of Insmed worth $1.21M as of Q1 2026.
Rockefeller Capital Management sold 9,346 Insmed shares in Q1 2026, an estimated $1.44M.
Insmed made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1522 holding.
Rockefeller Capital Management first reported a position in Insmed in Q1 2020 and has held it in 13 quarters since.
Rockefeller Capital Management's Insmed position peaked at $2.92M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.